Notably, HER2-enriched tumours exhibited the highest expression of these proteins, highlighting that HER2+ breast tumours demonstrate higher metabolic plasticity with elevated lipid metabolism compared to other subtypes [247]. This evidence concerns the gene ERBB2 and neoplasm.